Table 2.
Resistant Phenotype Percentages of Pseudomonas aeruginosa Isolates by 4-Year Period Over 20 Years of the SENTRY Program
| Resistant Phenotype a | 1997–2016 (n = 52 022) | 1997–2000(n = 9512) | 2001–2004 (n = 7928) | 2005–2008 (n = 7170) | 2009–2012(n = 10 951) | 2013–2016 (n = 16 461) |
|---|---|---|---|---|---|---|
| Multidrug resistant | 24.9% | 24.1% | 27.3% | 27.5% | 26.9% | 21.8% |
| Extensively drug resistant | 17.6% | 15.9% | 19.6% | 20.2% | 19.6% | 15.2% |
| Pandrug resistant | 0.1% | 0.0% | 0.0% | 0.1% | 0.1% | 0.1% |
| Ceftazidime nonsusceptible | 22.5% | 22.8% | 23.4% | 25.1% | 25.0% | 19.2% |
| Meropenem nonsusceptible | 23.9% | 19.3% | 24.9% | 26.6% | 27.3% | 22.6% |
aCriteria as published by European Committee on Antimicrobial Susceptibility Testing (EUCAST) 2018.